Updated:
InVivium Capital
InVivium Capital is a venture capital fund focused on investments in healthcare and life sciences. The firm seeks transformative solutions that provide a...
Overview
InVivium Capital is a venture capital fund focused on investments in healthcare and life sciences. The firm seeks transformative solutions that provide a step-change in value to patients, payers, and providers as well as pharma, biotech and med tech. It invests across the spectrum of innovation in healthcare, primarily focusing on biotechnology and medical device. Its mission is to work side by side with phenomenal people to bring transformational technologies to life.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Stamford, CT, United States
Additional offices
Chicago, IL · New York, NY
Principals
Michael Liang
Ph.D., Managing Partner
Amy Len Kobe
Partner
Christopher Cox
Partner
Alyse Passaglia
Vice President of HR & Operations
Shahryar Oveissi
Operating Partner
Christine Neipert
J.D., Ph.D., IP Advisor
Frequently asked questions
Does InVivium Capital manage commingled funds or invest deal-by-deal?
InVivium has not disclosed whether it operates through a traditional commingled fund structure, special purpose vehicles, or a deal-by-deal syndication model. The firm's private equity designation and early-to-growth-stage mandate are compatible with any of these structures, but the specific vehicle architecture is not part of the public record.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: